Verastem, Inc. (NASDAQ:VSTM) Q1 2026 Earnings Call Transcript May 7, 2026
Verastem, Inc. beats earnings expectations. Reported EPS is $-0.37, expectations were $-0.46.
Operator: Good afternoon, and welcome to Verastem Oncology’s First Quarter 2026 Earnings Conference Call. My name is Daniel, and I will be your call operator today. Please note, this event is being recorded. [Operator Instructions]. I will now turn the call over to Julissa Viana, Vice President of Corporate Communications,...
